The $5 Billion Opportunity For Sunshine Heart's C-Pulse DeviceSeeking AlphaHeartware's success can be a harbinger of things to come for Sunshine Heart (SSH), a company that also targets late-stage Congestive Heart Failure (CHF), albeit a far la…
IEHP targets one of nations most under-diagnosed diseases: Chronic Kidney … – Sacramento Bee
IEHP targets one of nations most under-diagnosed diseases: Chronic Kidney …Sacramento Bee2, 2012 — /PRNewswire-USNewswire/ — IEHP has launched a new Chronic Kidney Disease Program (CKD) that may delay the progression from early to advanced stages o…
Rock Climber Exceeds Expectations After Double-Lung Transplant
The 10,911-foot view from the top of Cathedral Peak in Yosemite National Park is a familiar sight for Rowan Jimenez. It marked a triumphant return from his double lung transplant surgery.
Transplantation Issues: Kidney Donors and Children in Need of Transplants
* Some kidney donors have an increased risk of developing high blood pressure after donation. * Individuals with prediabetes can safely donate kidneys without increasing their risk of developing diabetes or kidney failure. * Among children with advance…
Study Uncovers Link Between Chemotherapy Drug and Heart Failure – Asbestos.com
Asbestos.comStudy Uncovers Link Between Chemotherapy Drug and Heart FailureAsbestos.comA team of scientists at the University of Texas MD Anderson Cancer Center have solved a longstanding mystery about doxorubicin's role in the destruction of heart…
Rocker Climber Exceeds Expectations After Double-Lung Transplant
The 10,911-foot view from the top of Cathedral Peak in Yosemite National Park is a familiar sight for Rowan Jimenez. It marked a triumphant return from his double lung transplant surgery.
IPAB sets aside Indian patent for Roche's Hepatitis C drug – Business Standard
LivemintIPAB sets aside Indian patent for Roche's Hepatitis C drugBusiness Standard… which if not treated, would lead to liver cirrhosis, liver failure and liver cancer, according to the Trust's statement. The patent, granted to Roche in 2006…
Emergent BioSolutions initiates Phase Ib chronic lymphocytic leukemia study – Equities.com
Emergent BioSolutions initiates Phase Ib chronic lymphocytic leukemia studyEquities.comNov 02, 2012 (Datamonitor via COMTEX) — Emergent BioSolutions Inc., a biopharmaceutical company, has announced the initiation of a Phase Ib study, or Protocol 16009…
Tuberous Sclerosis Skin Lesions Improved on Everolimus – The Oncology Report
Tuberous Sclerosis Skin Lesions Improved on EverolimusThe Oncology ReportPRAGUE – Everolimus significantly improved the skin lesions of tuberous sclerosis complex in two phase-III clinical trials, Dr. Sergiusz Jozwiak reported at the annual congress …
India board revokes Roche hepatitis patent – FRANCE 24
FRANCE 24India board revokes Roche hepatitis patentFRANCE 24The Intellectual Property Appellate Board overturned the patent awarded by the Indian Patent Office to Hoffmann-La Roche's drug Pegasys used to treat hepatitis C — a disease that can lead…